Topic

Aetna (CVS Health)

A collection of 1351 issues

Work With Your Doctor to Get Epidiolex (Cannabidiol) Approved by Aetna (CVS Health) in North Carolina: Forms, Appeals, and State Protections

How to Get Epidiolex (Cannabidiol) Covered by Aetna (CVS Health) in North Carolina Quick Answer: Aetna (CVS Health) covers Epidiolex for Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex with prior authorization and often step therapy. Your neurologist must document failed trials of standard antiseizure medications and submit a medical
7 min read

How to Get Trikafta Covered by Aetna CVS Health in Pennsylvania: Complete Prior Authorization and Appeals Guide 2025

Answer Box: Getting Trikafta Covered by Aetna CVS Health in Pennsylvania Trikafta requires prior authorization from Aetna CVS Health with specific documentation: CF diagnosis, CFTR genotype (F508del or responsive mutation), age ≥2 years, and specialist prescription. Submit via CVS Specialty at 1-800-237-2767 with required labs and clinical notes. Standard approval
7 min read

How to Get Gattex (Teduglutide) Covered by Aetna CVS Health in Georgia: Complete Appeals Guide with Forms and Timelines

Quick Answer: To get Gattex (teduglutide) covered by Aetna CVS Health in Georgia, you need documented short bowel syndrome with parenteral nutrition dependence, specialist involvement, and baseline colon screening. Submit prior authorization through CVS Specialty with detailed PN logs. If denied, file internal appeals within 180 days, then Georgia external
6 min read

Work With Your Doctor to Get Abecma (idecabtagene vicleucel) Covered by Aetna (CVS Health) in North Carolina: Complete Appeals Guide

Answer Box: Getting Abecma Covered by Aetna in North Carolina Eligibility: Adults with relapsed/refractory multiple myeloma after ≥2 prior lines including an IMiD, proteasome inhibitor, and anti-CD38 antibody. Fastest path: Work with your oncologist at a certified CAR-T center to submit a comprehensive prior authorization with documented treatment failures
8 min read